Apionex Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2018.
2018 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Apionex Pharma Private Limited

Apionex Pharma Private Limited, a active private limited company, was established on 05 October 2018 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U33209MH2018PTC315329. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.00 M.

Its leadership includes Nirav Vinod Shah (Director), Nikita Nirav Shah (Director Appointed In Casual Vacancy), Chintal Tejas Laliwala (Additional Director). Past directors included Akash Mishra, Pratik Mohan Agnihotri. It holds ₹2.18 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1206, Plot No 856, Ghanshyam Enclave Link Road, Lalji Pada, Kandivali (West), Mumbai, Maharashtra, 400067.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33209MH2018PTC315329

  • Registration Number

    315329

  • Incorporation Date

    05 October 2018

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 7 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.18 Cr
  • Revenue Growth **** 3.77%
  • Profit Growth **** 55.75%
  • Ebitda **** 54.82%
  • Net Worth 116.41%
  • Total Assets **** 10.49%
Company report

Apionex Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Apionex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Apionex Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Nirav Vinod Shah Director 05 Oct 2018 Current
Nikita Nirav Shah Director Appointed In Casual Vacancy 09 Dec 2024 Current
Chintal Tejas Laliwala Additional Director 11 Dec 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jul 2024 Past
Pramod Abcsdd Director 10 Nov 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Apionex Pharma.

Apionex Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.77% increase. The company also saw a substantial improvement in profitability, with a 55.75% increase in profit. The company's net worth Soared by an impressive increase of 116.41%.

Apionex Pharma revenue growth over time
Apionex Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.77%
*******
*******
*******
*******
Revenue from Operations
*******
 3.77%
*******
*******
*******
*******
Total Assets
*******
 10.49%
*******
*******
*******
*******
Profit or Loss
*******
 55.75%
*******
*******
*******
*******
Net Worth
*******
 116.41%
*******
*******
*******
*******
EBITDA
*******
 54.82%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Apionex Pharma?

In 2023, Apionex Pharma had a public holding of 2.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹21,800,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 2.18 Cr
Latest Charge Details
Date Lender Amount Status
03 May 2025 Hdfc Bank Limited ₹1.80 M Open
29 Jan 2022 Hdfc Bank Limited ₹2.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Apionex Pharma?

Unlock and access historical data on people associated with Apionex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Apionex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apionex Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Apionex Pharma
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.80 M with Charge ID 101097517 was registered on 03 May 2025. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 20.00 M registered on 29 Jan 2022 with Charge ID 100534981 was modified on 26 Dec 2024. was completed.

  • Director Appointment

    Progress on Chintal Tejas Laliwala was appointed as a Additional Director was appointed as a Additional Director on 11 Dec 2024 & has been associated with this company since 1 year 2 months . was documented.

  • Director Appointment

    Nikita Nirav Shah was appointed as a Director appointed in casual vacancy was appointed as a Director appointed in casual vacancy on 09 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.

  • Annual General Meeting

    The activity Apionex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Apionex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Apionex Pharma Private Limited?

The CIN of Apionex Pharma Private Limited is U33209MH2018PTC315329.

Where is Apionex Pharma Private Limited headquartered?

Apionex Pharma Private Limited is headquartered at 1206, Plot No 856, Ghanshyam Enclave Link Road, Lalji Pada, Kandivali (West), Mumbai, Maharashtra, 400067.

When was Apionex Pharma Private Limited incorporated?

Apionex Pharma Private Limited was incorporated on 05 October 2018.

Who are the current directors of Apionex Pharma Private Limited?

The current directors of Apionex Pharma Private Limited are

What is the primary industry of Apionex Pharma Private Limited?

The primary industry of Apionex Pharma Private Limited is Manufacturing.

Is Apionex Pharma Private Limited a listed company?

Apionex Pharma Private Limited is unlisted.

What is the capital structure of Apionex Pharma Private Limited?

The authorized capital of Apionex Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available